GSK losing a bid to keep experts out of an upcoming Zantac trial.
A California judge on Thursday denied GSK Plc's bid to keep expert testimony linking its discontinued heartburn drug Zantac to cancer out of an upcoming trial, a setback for the British drugmaker facing lawsuits over the medicine in courts across the United States. Analysts said that while Alameda